Phase 3 Kidney Cancer Trial, Recruiting NCT06349668 Sponsor: Hans Bahlmann Condition: Kidney Cancer
Back to Kidney Cancer

Phase 3 Kidney Cancer Trial, Recruiting

NCT06349668
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are scheduled for a planned (non-emergency) robotic-assisted surgery on the upper part of the urinary tract at one of the hospitals taking part in this study
  • You are willing to give your agreement to take part, both verbally and in writing, after being fully informed about the study

Who may not be able to join:

  • You have been rated as being in very poor general health before surgery (known as ASA class IV or above — confirm with trial site if unsure what this means for you)
  • You are under 18 years old, have been legally declared unable to make your own decisions, have a severe psychiatric illness, or are not able to understand the study information due to serious difficulties with vision, hearing, thinking, reading, or understanding Swedish
  • You are pregnant or currently breastfeeding
  • You are a woman who has not yet gone through menopause, has not had certain sterilisation procedures, and is not using a highly reliable form of contraception, or cannot provide a negative pregnancy test
  • You are scheduled for emergency surgery
  • The research team is not available at the time of your surgery
  • You are having another major operation on a different organ at the same time
  • Your anaesthetist has already planned to use spinal or epidural pain relief for your surgery
  • You have medical reasons why spinal pain relief would not be safe for you, such as serious blood clotting problems, a severe heart valve condition, previous back surgery with metal rods, severe obesity, or severe curvature of the spine (confirm with trial site)
  • You have medical reasons why a lidocaine drip (a type of local anaesthetic given through a vein) would not be safe for you, such as a known allergy to local anaesthetics, a muscle condition called myasthenia gravis, severe kidney problems, severe liver disease, or serious heart rhythm or heart function problems (confirm with trial site)
  • You have already taken part in this trial before

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Martin Holmberg, University Hospital, Linkoeping

Phone: +46739312281

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Hans Bahlmann
Registry
ClinicalTrials.gov
Start date
9 April 2024
Est. completion
1 October 2027

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

QoR-15 score at postoperative day 1

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov